Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |